Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Otilonium bromide

Otilonium bromide

26095-59-0

DISCOVER
Olmesartan Medoxomil

Olmesartan Medoxomil

144689-63-4

DISCOVER
Oxibendazole-amine HCl

Oxibendazole-amine HCl

1538624-34-8

DISCOVER
Oxytocin Acetate

Oxytocin Acetate

6233-83-6

DISCOVER
Orphenadrine citrate salt

Orphenadrine citrate salt

4682-36-4

DISCOVER
Olaquindox

Olaquindox

23696-28-8

DISCOVER
Oxyphenbutazone

Oxyphenbutazone

129-20-4

DISCOVER
Ofloxacin D3

Ofloxacin D3

1173021-78-7

DISCOVER
Oleandomycin phosphate

Oleandomycin phosphate

7060-74-4

DISCOVER
(±)-Oxazepam D5 (phenyl D5)

(±)-Oxazepam D5 (phenyl D5)

65854-78-6

DISCOVER
(S)-(-)-Ofloxacin D3 (N-methyl D3)

(S)-(-)-Ofloxacin D3 (N-methyl D3)

1173147-91-5

DISCOVER
Olanzapine D3 (4-methyl D3-piperazinyl)

Olanzapine D3 (4-methyl D3-piperazinyl)

786686-79-1

DISCOVER